Paysign, Inc. (NASDAQ:PAYS) Insider Topline Capital Management, Ll Sells 120,000 Shares of Stock

Paysign, Inc. (NASDAQ:PAYSGet Free Report) insider Topline Capital Management, Ll sold 120,000 shares of the firm’s stock in a transaction on Tuesday, January 14th. The shares were sold at an average price of $3.24, for a total transaction of $388,800.00. Following the completion of the transaction, the insider now directly owns 5,336,146 shares in the company, valued at approximately $17,289,113.04. This represents a 2.20 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Topline Capital Management, Ll also recently made the following trade(s):

  • On Monday, December 30th, Topline Capital Management, Ll sold 227,084 shares of Paysign stock. The stock was sold at an average price of $3.07, for a total transaction of $697,147.88.
  • On Friday, December 27th, Topline Capital Management, Ll sold 231,187 shares of Paysign stock. The shares were sold at an average price of $3.31, for a total value of $765,228.97.

Paysign Price Performance

NASDAQ:PAYS opened at $3.07 on Thursday. Paysign, Inc. has a 1-year low of $2.48 and a 1-year high of $5.59. The stock has a market cap of $164.40 million, a P/E ratio of 20.47 and a beta of 0.95. The firm has a 50-day moving average of $3.25 and a two-hundred day moving average of $3.94.

Paysign (NASDAQ:PAYSGet Free Report) last issued its quarterly earnings results on Tuesday, November 5th. The company reported $0.03 EPS for the quarter, beating analysts’ consensus estimates of $0.01 by $0.02. Paysign had a return on equity of 30.64% and a net margin of 14.28%. The firm had revenue of $15.26 million during the quarter, compared to the consensus estimate of $14.96 million. During the same quarter in the prior year, the business posted $0.02 earnings per share. As a group, equities analysts expect that Paysign, Inc. will post 0.21 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on the company. Barrington Research reiterated an “outperform” rating and issued a $7.00 target price on shares of Paysign in a research note on Monday, November 4th. Lake Street Capital assumed coverage on shares of Paysign in a research report on Friday, December 20th. They issued a “buy” rating and a $6.00 price objective for the company.

Check Out Our Latest Report on Paysign

Institutional Trading of Paysign

A number of hedge funds have recently made changes to their positions in PAYS. Bank of New York Mellon Corp raised its holdings in Paysign by 5.2% in the second quarter. Bank of New York Mellon Corp now owns 85,964 shares of the company’s stock valued at $371,000 after acquiring an additional 4,248 shares in the last quarter. Sanctuary Advisors LLC increased its position in shares of Paysign by 4.3% in the 3rd quarter. Sanctuary Advisors LLC now owns 121,089 shares of the company’s stock worth $419,000 after purchasing an additional 5,000 shares during the last quarter. Rhumbline Advisers raised its stake in shares of Paysign by 25.1% in the 2nd quarter. Rhumbline Advisers now owns 35,835 shares of the company’s stock valued at $154,000 after purchasing an additional 7,190 shares in the last quarter. Algert Global LLC bought a new position in shares of Paysign during the second quarter worth about $46,000. Finally, SG Americas Securities LLC bought a new position in shares of Paysign during the third quarter worth about $43,000. Institutional investors and hedge funds own 25.89% of the company’s stock.

About Paysign

(Get Free Report)

Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.

Further Reading

Insider Buying and Selling by Quarter for Paysign (NASDAQ:PAYS)

Receive News & Ratings for Paysign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paysign and related companies with MarketBeat.com's FREE daily email newsletter.